📰 World Dynamix News
World Dynamix News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from World Dynamix. Real-time updates on events, politics, business and more.
August 15, 2023
Spherix Global Insights finds doctors have yet to define where APT-1011 will sit in the treatment path relative to EoE treatment gold standard, Dupixent....
July 28, 2023
Prospects for Syfovre uptake and trust in Apellis take a plunge following reports of intraocular inflammation, according to Spherix Global Insights...
June 15, 2023
In the third annual patient chart analysis, major treatment shifts in biologic use and average daily steroid dose were observed....
April 14, 2023
/PRNewswire/ -- Spherix Global Insights recently released data from their Launch Dynamix™: Trudhesa in Acute Treatment of Migraine (US) deep dive study...
February 28, 2023
/PRNewswire/ -- On February 16, The Lancet Neurology published the Phase 3 results of Pfizers zavegepant for the acute treatment of migraine. The CGRP...
February 24, 2023
/PRNewswire/ -- Argenxs launch of Vyvgart (efgartigimod) has been a success, with global first-year revenue of ~$400 million USD. As the second biologic...
February 17, 2023
/PRNewswire/ -- According to Biogens earnings call on Wednesday, February 15, 2023, sales for its multiple sclerosis (MS) franchise are down for the third...
February 13, 2023
/PRNewswire/ -- The patient switch territory is evolving as more agents become available. Spherixs RealWorld Dynamix™ report allows for an inside look into...
February 9, 2023
/PRNewswire/ -- Since 2017, Spherix Global Insights has been monitoring the U.S. renal anemia market landscape, capturing nephrologists perceptions and...
January 20, 2023
/PRNewswire/ -- With SGLT2 inhibitors increasingly becoming the standard of care for diabetic and non-diabetic CKD patients, the broader CKD treatment has...